Quinone Oxidoreductase 1 (NQO1) is an
antioxidant enzyme that catalyzes the two-electron reduction of several different classes of
quinone-like compounds (
quinones,
quinone imines, nitroaromatics, and
azo dyes). One-electron reduction of
quinone or
quinone-like metabolites is considered to generate semiquinones to initiate redox cycling that is responsible for the generation of
reactive oxygen species and oxidative stress and may contribute to the initiation of
adverse drug reactions and adverse health effects. On the other hand, the two-electron reduction of quinoid compounds appears important for drug activation (bioreductive activation) via chemical rearrangement or autoxidation. Two-electron reduction decreases
quinone levels and opportunities for the generation of reactive species that can deplete intracellular
thiol pools. Also, studies have shown that induction or depletion (knockout) of NQO1 were associated with decreased or increased susceptibilities to oxidative stress, respectively. Moreover, another member of the
quinone reductase family, NRH:
Quinone Oxidoreductase 2 (
NQO2), has a significant functional and structural similarity with NQO1. The activity of both
antioxidant enzymes, NQO1 and
NQO2, becomes critically important when other detoxification pathways are exhausted. Therefore, this article summarizes the interactions of NQO1 and
NQO2 with different pharmacological agents, endogenous biochemicals, and environmental contaminants that would be useful in the development of therapeutic approaches to reduce the
adverse drug reactions as well as protection against
quinone-induced oxidative damage. Also, future directions and areas of further study for NQO1 and
NQO2 are discussed.